If investors focused on the economic cost of losses relative to the benefit of gains, they would likely change their perspective on performance evaluation.

FORBES: Peace Of Mind Performance In Stocks

"We want healthcare professionals and patients to have the most current information on the risks of statins, but also to assure them that these medications continue to provide an important health benefit of lowering cholesterol, " said Dr. Mary Parks, in the FDA's Center for Drug Evaluation and Research.

CNN: Statin labels will come with new safety warnings